Gene · 5566
Papers2,763
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,763
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CONSTRUCT: an algorithmic tool for identifying functional or structurally important regions in protein tertiary structure. | Bioinformatics | 2025 | 40220324 | PubTator, text mining | PubMed |
| Correction: DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming. | Cancer Discov | 2025 | 40170541 | PubTator, text mining | PubMed |
| A Rare Case of PRKACA Duplication-Associated Childhood-Onset Primary Pigmented Nodular Adrenocortical Disease. | JCEM Case Rep | 2025 | 40066253 | PubTator, text mining | PubMed |
| Nsun2 controls cardiac homeostasis and hypertrophic response by regulating PRKACA expression. | Theranostics | 2025 | 39990213 | PubTator, text mining | PubMed |
| The proteomic landscape of diffuse midline glioma highlights the therapeutic potential of non-histone protein methyltransferases. | Neuro Oncol | 2025 | 39954016 | PubTator, text mining | PubMed |
| A novel high-throughput screening platform to identify inhibitors of DNAJB1-PRKACA-driven transcriptional activity in fibrolamellar carcinoma. | SLAS Discov | 2025 | 39947627 | PubTator, text mining | PubMed |
| ccfDNA analysis for the classification of adrenocortical adenomas. | J Endocrinol Invest | 2025 | 39891827 | PubTator, text mining | PubMed |
| Network pharmacology alliance with experimental validation unveils the anti-colorectal cancer mechanism of Xianlian Jiedu decoction. | J Ethnopharmacol | 2025 | 39842746 | PubTator, text mining | PubMed |
| LCAT deficiency promotes hepatocellular carcinoma progression and lenvatinib resistance by promoting triglyceride catabolism and fatty acid oxidation. | Cancer Lett | 2025 | 39842501 | PubTator, text mining | PubMed |
| PTMNavigator: interactive visualization of differentially regulated post-translational modifications in cellular signaling pathways. | Nat Commun | 2025 | 39779715 | PubTator, text mining | PubMed |
| Unveiling the substantial role of rutin in the management of drug-induced nephropathy using network pharmacology and molecular docking. | Int Immunopharmacol | 2025 | 39733639 | PubTator, text mining | PubMed |
| Genetic and allelic heterogeneity in 248 Indians with skeletal dysplasia. | Eur J Hum Genet | 2025 | 39706863 | PubTator, text mining | PubMed |
| Unraveling the potential of Epicatechin gallate from crataegus oxyacantha in targeting aberrant cardiac Ca2+ signalling proteins: an in-depth in-silico investigation for heart failure therapy. | J Biomol Struct Dyn | 2025 | 39648361 | PubTator, text mining | PubMed |
| Diagnostic and therapeutic approaches to a case of pregnancy complicated by bilateral adrenocortical adenomas with primary aldosteronism and Cushing's syndrome. | Endocrine | 2025 | 39375255 | PubTator, text mining | PubMed |
| Anti-liver cancer therapeutic targets and safety of usenamine A in experimental liver cancer. | J Pharm Pharmacol | 2025 | 39360781 | PubTator, text mining | PubMed |
| DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming. | Cancer Discov | 2025 | 39326063 | PubTator, text mining | PubMed |
| Nanodomain cAMP signaling in cardiac pathophysiology: potential for developing targeted therapeutic interventions. | Physiol Rev | 2025 | 39115424 | PubTator, text mining | PubMed |
| The Combination of Resveratrol and Conjugated Linoleic Acid Dienes Enhances the Individual Effects of These Molecules on De Novo Fatty Acid Biosynthesis in 3T3-L1 Adipocytes. | Int J Mol Sci | 2024 | 39769194 | PubTator, text mining | PubMed |
| Liver cancer multiomics reveals diverse protein kinase A disruptions convergently produce fibrolamellar hepatocellular carcinoma. | Nat Commun | 2024 | 39738196 | PubTator, text mining | PubMed |
| Network Pharmacology and Molecular Docking Study on the Mechanism of the Therapeutic Effect of Strychni Semen in NSCLC. | Biol Proced Online | 2024 | 39736533 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5566/papers?page=6